Filtered By:
Vaccination: Cancer Vaccines

This page shows you your search results in order of relevance. This is page number 5.

Order by Relevance | Date

Total 2459 results found since Jan 2013.

Application of P4 (Predictive, Preventive, Personalized, Participatory) Approach to Occupational Medicine
Med Lav. 2022 Feb 22;113(1):e2022009. doi: 10.23749/mdl.v113i1.12622.ABSTRACTIn recent years there has been a growth in the role of prevention in controlling the disease burden. Increasing efforts have been conveyed in the screening implementation and public health policies, and the spreading knowledge on risk factors reflects on major attention to health checks. Despite this, lifestyle changes are difficult to be adopted and the adherence to current public health services like screening and vaccinations remains suboptimal. Additionally, the prevalence and outcome of different chronic diseases and cancers is burdened by so...
Source: Medicina del Lavoro - February 28, 2022 Category: Occupational Health Authors: Paolo Boffetta Giulia Collatuzzo Source Type: research

Long Waits, Short Appointments, Huge Bills: U.S. Health Care Is Causing Patient Burnout
You haven’t been feeling well lately. You’re more tired than usual, a bit sluggish. You wonder if there’s something wrong with your diet. Or maybe you’re anemic? You call your primary-­care doctor’s office to schedule an appointment. They inform you the next available appointment is in three weeks. So, you wait. And then you wait some more. And then, when you arrive on the day of your appointment, you wait even more. You fill out the mountain of required paperwork, but the doctor still isn’t ready to see you. You flip through a magazine for a while, then scroll through your phone unt...
Source: TIME: Health - February 27, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized feature healthscienceclimate Magazine medicine Source Type: news

2-step immunotherapy attacks advanced ovarian cancer
(University of Pennsylvania School of Medicine) Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment -- a dendritic cell vaccine using patients' own tumor followed by adoptive T cell therapy -- triggers anti-tumor immune responses in these type of patients. The investigators report on initial results of the approach this month in OncoImmunology.
Source: EurekAlert! - Medicine and Health - January 31, 2013 Category: Global & Universal Source Type: news

Sun and skin – Is travel health advice needed?
I would like to comment on the topic of “sun and skin” in the context of travel medicine Western images portray people with a tanned skin as exemplifying good health, when in fact, the reverse is the truth. Tanned skin has been damaged in the body's effort to protect against the suns' ultra-violet (UV) rays. Holiday brochures and travel magazines showcase images of travellers with bronzed skin as a feature of their adventures and a transient souvenir to take home. Travel health professionals have a role to play in the prevention of harm to travellers by carrying out risk assessments prior to travel. It is within these...
Source: Travel Medicine and Infectious Disease - November 11, 2013 Category: Infectious Diseases Authors: Cate Wood Tags: Correspondence Source Type: research

Human Papilloma Virus (HPV) Infection and HPV Vaccination: Assessing the Level of Knowledge among Students of the University of Medicine and Pharmacy of Tirgu Mures, Romania
Conclusions: The level of knowledge about HPV infection among students in their first year of medicine school is rather low, significantly lower compared to year 6th year students, which suggests acquiring some basic information in this area since the first year of college or even high school.
Source: Acta Dermatovenerologica Croatica - September 13, 2016 Category: Dermatology Source Type: research

Two-Step Immunotherapy Attacks Advanced Ovarian Cancer, Penn Medicine Researchers Report
Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment - a dendritic cell vaccine using patients' own tumor followed by adoptive T cell therapy - triggers anti-tumor immune responses in these type of patients. Four of the six patients treated in the trial responded to the therapy, the investigators report this month in OncoImmunology...
Source: Health News from Medical News Today - February 4, 2013 Category: Consumer Health News Tags: Ovarian Cancer Source Type: news